The association between GGCX, miR-133 genetic polymorphisms and warfarin stable dosage in Han Chinese patients with mechanical heart valve replacement

被引:9
|
作者
Tang, X. -Y. [1 ,2 ]
Zhang, J. [3 ]
Peng, J. [1 ,2 ,4 ]
Tan, S. -I. [5 ]
Zhang, W. [1 ,2 ]
Song, G. -B. [5 ]
Liu, L. -M. [3 ]
Li, C. -L. [1 ,2 ]
Ren, H. [1 ,2 ]
Zeng, L. [1 ,2 ]
Liu, Z. -Q. [1 ,2 ]
Chen, X. -P. [1 ,2 ]
Zhou, X. -M. [3 ]
Zhou, H. -H. [1 ,2 ]
Hu, J. -x. [5 ]
Li, Z. [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R China
[4] Jiangxi Prov Peoples Hosp, Dept Pharm, Nanchang, Jiangxi, Peoples R China
[5] CentralSouth Univ, Dept Cardiothorac Surg, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
关键词
GGCX; heart valve replacement; mir-133; gene; polymorphisms; VKORC1; warfarin; GAMMA-GLUTAMYL-CARBOXYLASE; K EPOXIDE REDUCTASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; CYTOCHROME P4502C9; DOSE PREDICTION; FACTOR-VII; CYP4F2; DETERMINANTS; VARIANTS; VKORC1;
D O I
10.1111/jcpt.12527
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objectiveWarfarin is a widely used anticoagulant with a narrow therapeutic index. Polymorphisms in the VKORC1, CYP2C9 and CYP4F2 genes have been verified to correlate with warfarin stable dosage (WSD). Whether any other genes or variants affect the dosage is unknown. The aim of our study was to investigate the relationship between GGCX, miR-133 variants and the WSD in Han Chinese patientswith mechanical heart valve replacement (MHVR). MethodsA total of 231 patients were enrolled in the study. Blood samples were collected for genotyping. The average WSD among subjects with different GGCX or miR-133 genotypes was compared. Regression analyses were performed to test for any association of genetic polymorphisms with WSD. Results and discussionThe warfarin dosage in patients with the GGCX rs699664 TT and rs12714145 TT genotypes was 3.770.93 (95% CI: 3.35-4.19) mg/d and 3.70 +/- 1.00 (95% CI: 3.32-4.09) mg/d, respectively. The GGCX rs699664 and rs12714145 genotypes were significantly associated with WSD (P<.05). But they were ruled out in the multivariate regression analysis. There were no significant differences in the average warfarin stable dosage between subjects with MIR133B rs142410335 wild-type and variant genotypes (P>.05). What is new and conclusionThe genotypes of GGCX rs699644 and rs12714145 were significantly associated with WSD (P<.05), but their contributions were not significant after accounting for other factors. MIR133B rs142410335 makes no significant contributions to warfarin stable dosage in Han Chinese patientswith MHVR neither in univariate regression nor in multivariate regression analyses.
引用
收藏
页码:438 / 445
页数:8
相关论文
共 18 条
  • [1] Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement
    Tan, Sheng-Lan
    Li, Zhi
    Zhang, Wei
    Song, Guo-Bao
    Liu, Li-Ming
    Peng, Juan
    Liu, Zhao-Qian
    Fan, Lan
    Meng, Xiang-Guang
    Wang, Lian-Sheng
    Chen, Yao
    Zhou, Xin-Min
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (10) : 1769 - 1775
  • [2] Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement
    Sheng-Lan Tan
    Zhi Li
    Wei Zhang
    Guo-Bao Song
    Li-Ming Liu
    Juan Peng
    Zhao-Qian Liu
    Lan Fan
    Xiang-Guang Meng
    Lian-Sheng Wang
    Yao Chen
    Xin-Min Zhou
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2013, 69 : 1769 - 1775
  • [3] The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement
    Zhong, Shi-Long
    Liu, Yuan
    Yu, Xi-Yong
    Xu, Dan
    Tan, Hong-Hong
    Lin, Qiu-Xiong
    Yang, Min
    Lao, Hai-Yan
    Lin, Shu-Guang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (06) : 581 - 590
  • [4] The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement
    Shi-Long Zhong
    Yuan Liu
    Xi-Yong Yu
    Dan Xu
    Hong-Hong Tan
    Qiu-Xiong Lin
    Min Yang
    Hai-Yan Lao
    Shu-Guang Lin
    European Journal of Clinical Pharmacology, 2011, 67 : 581 - 590
  • [5] Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
    Liu, Rui
    Cao, Jian
    Zhang, Qian
    Shi, Xin-Miao
    Pan, Xiao-Dong
    Dong, Ran
    MEDICINE, 2017, 96 (02)
  • [6] Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery
    Ma, Siqing
    Luo, Zhiying
    Zhou, Xinmin
    Zhou, Honghao
    Chen, Ling
    Zhang, Wei
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (02) : 212 - 218
  • [7] CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
    Cen, Han-Jing
    Zeng, Wu-Tao
    Leng, Xiu-Yu
    Huang, Min
    Chen, Xiao
    Li, Jia-Li
    Huang, Zhi-Ying
    Bi, Hui-Chang
    Wang, Xue-Ding
    He, Yan-Ling
    He, Fan
    Zhou, Rui-Na
    Zheng, Qi-Shan
    Zhao, Li-Zi
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 234 - 240
  • [8] Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement
    Li, Jin
    Chen, Tao
    Jie, Fangfang
    Xiang, Haiyan
    Huang, Li
    Jiang, Hongfa
    Lu, Fei
    Zhu, Shuqiang
    Wu, Lidong
    Tang, Yanhua
    MEDICINE, 2022, 101 (29) : E29626
  • [9] Association between gene polymorphisms and initial warfarin therapy in patients after heart valve surgery
    Liu, Zhaohui
    Luo, Fengming
    Zhao, Juan
    Chen, Weinan
    Gao, Wei
    Zhou, Zhou
    PHARMACOLOGICAL REPORTS, 2024, 76 (02) : 390 - 399
  • [10] Association between gene polymorphisms and initial warfarin therapy in patients after heart valve surgery
    Zhaohui Liu
    Fengming Luo
    Juan Zhao
    Weinan Chen
    Wei Gao
    Zhou Zhou
    Pharmacological Reports, 2024, 76 : 390 - 399